Pulse Biosciences Inc (PLSE)

Currency in USD
19.52
-0.60(-2.98%)
Real-time Data·
PLSE is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
19.3020.50
52 wk Range
12.5626.30
Key Statistics
Prev. Close
20.12
Open
20.31
Day's Range
19.3-20.5
52 wk Range
12.56-26.3
Volume
131.65K
Average Vol. (3m)
349.25K
1-Year Change
14.6213%
Book Value / Share
1.19
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PLSE Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
30.00
Upside
+53.69%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Pulse Biosciences Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system for soft tissue ablation in surgical setting; nPulse Cardiac Surgical Clamp designed for use in surgical treatment of atrial fibrillation (AF); nPulse Cardiac Catheter System designed to provide a circumferential, or circular, ablation in a single treatment cycle; and nPulse Console, a software-enabled console-based platform designed to accommodate the clinical workflow preferred by physicians. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Miami, Florida.

Pulse Biosciences Inc Earnings Call Summary for Q3/2025

  • Pulse Biosciences reported Q3 2025 revenue of $86,000 from initial sales of N-Pulse Capital and Vibrance products, despite posting a GAAP net loss of $19.4 million
  • The company received FDA IDE approval for its M-Pulse cardiac surgical system and successfully launched the M-Pulse Technology platform
  • GAAP costs increased by $6.8 million year-over-year to $20.5 million, with non-cash stock-based compensation accounting for 38% of the increase
  • Cash position remains strong at $95.2 million as of September 30, 2025, with management focusing on building 'a viable organization for the long term'
  • Future growth strategy includes expanding procedure and disposable sales, pursuing strategic partnerships in electrophysiology ablation, and advancing upcoming clinical trials
Last Updated: 11/05/2025, 05:17 PM
Read Full Transcript

Compare PLSE to Peers and Sector

Metrics to compare
PLSE
Peers
Sector
Relationship
P/E Ratio
−18.4x−3.6x−0.5x
PEG Ratio
1.06−0.050.00
Price / Book
16.6x4.1x2.6x
Price / LTM Sales
3,817.1x3.3x3.2x
Upside (Analyst Target)
49.1%42.0%47.6%
Fair Value Upside
Unlock8.2%6.1%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 30.00
(+53.69% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Oppenheimer
Buy30.00+53.69%22.00MaintainFeb 20, 2026
Mizuho
Buy30.00+53.69%25.00MaintainFeb 06, 2026
Mizuho
Buy25.00+28.07%-New CoverageJan 30, 2026
Oppenheimer
Buy22.00+12.70%-New CoverageJul 07, 2025

Earnings

Latest Release
Feb 19, 2026
EPS / Forecast
-0.26 / -0.33
Revenue / Forecast
264K / 750K
EPS Revisions
Last 90 days

PLSE Income Statement

People Also Watch

39.890
LQDA
+3.05%
9.925
PTEN
+0.46%
38.73
VIAV
-5.04%
819.91
LITE
-3.86%
120.39
CF
+1.20%

FAQ

What Is the Pulse Biosciences (PLSE) Stock Price Today?

The Pulse Biosciences stock price today is 19.52 USD.

What Stock Exchange Does Pulse Biosciences Trade On?

Pulse Biosciences is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Pulse Biosciences?

The stock symbol for Pulse Biosciences is "PLSE."

What Is the Pulse Biosciences Market Cap?

As of today, Pulse Biosciences market cap is 1.33B USD.

What Is Pulse Biosciences's Earnings Per Share (TTM)?

The Pulse Biosciences EPS (TTM) is -1.08.

When Is the Next Pulse Biosciences Earnings Date?

Pulse Biosciences will release its next earnings report on May 07, 2026.

From a Technical Analysis Perspective, Is PLSE a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Pulse Biosciences Stock Split?

Pulse Biosciences has split 0 times.

How Many Employees Does Pulse Biosciences Have?

Pulse Biosciences has 116 employees.

What is the current trading status of Pulse Biosciences (PLSE)?

As of Apr 15, 2026, Pulse Biosciences (PLSE) is trading at a price of 19.52 USD, with a previous close of 20.12 USD. The stock has fluctuated within a day range of 19.30 USD to 20.50 USD, while its 52-week range spans from 12.56 USD to 26.30 USD.

What Is Pulse Biosciences (PLSE) Price Target According to Analysts?

The average 12-month price target for Pulse Biosciences is 30.00 USD, with a high estimate of 30 USD and a low estimate of 30 USD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +53.69% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.